These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7357520)

  • 21. Sequential high-dose cytosine arabinoside-asparaginase treatment in advanced childhood leukemia.
    Wells RJ; Feusner J; Devney R; Woods WG; Provisor AJ; Cairo MS; Odom LF; Nachman J; Jones GR; Ettinger LJ
    J Clin Oncol; 1985 Jul; 3(7):998-1004. PubMed ID: 3860629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [VP 16-213 in the treatment of acute leukemia in childhood].
    Esumi N; Arakawa S; Imashuku S
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):848-51. PubMed ID: 6576730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
    Kung FH; Nythan WL; Cuttner J; Falkson G; Lanzkowsky P; Del Duca V; Nawabi IU; Koch K; Pluess H; Freeman A; Burgert EO; Leone LA; Ruymann F; Patterson RB; Degnan T; Hakami N; Pajak TF; Holland J
    Cancer; 1978 Feb; 41(2):428-34. PubMed ID: 272945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etoposide (VP-16) with prednisone and vincristine for the treatment of refractory acute lymphoblastic leukemia.
    Abromowitch M; Bowman WP; Ochs J; Rivera G
    J Clin Oncol; 1985 Jun; 3(6):789-92. PubMed ID: 3859585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission.
    Rivera G; Murphy SB; Aur RJ; Verzosa MS; Dahl GV; Mauer AM
    Cancer; 1978 Dec; 42(6):2521-8. PubMed ID: 282003
    [No Abstract]   [Full Text] [Related]  

  • 26. High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.
    Hiddemann W; Kreutzmann H; Straif K; Ludwig WD; Mertelsmann R; Planker M; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):73-7. PubMed ID: 3473685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of acute refractory lymphoblastic leukemia in the adult with VM-26 and ARA-C].
    Rafecas FJ; Sanz MA
    Sangre (Barc); 1984; 29(6):1052-3. PubMed ID: 6598235
    [No Abstract]   [Full Text] [Related]  

  • 28. VM26 therapy in children with drug-refractory lymphocytic leukemia.
    Rivera G; Dahl GV; Murphy SB; Bowman WP; Aur RJ; Avery TL; Simone JV
    Cancer Chemother Pharmacol; 1982; 7(2-3):169-72. PubMed ID: 7083458
    [No Abstract]   [Full Text] [Related]  

  • 29. The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia.
    Rivera GK
    J Clin Oncol; 1988 Feb; 6(2):191-3. PubMed ID: 3276820
    [No Abstract]   [Full Text] [Related]  

  • 30. Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study.
    Rivera GK; Buchanan G; Boyett JM; Camitta B; Ochs J; Kalwinsky D; Amylon M; Vietti TJ; Crist WM
    N Engl J Med; 1986 Jul; 315(5):273-8. PubMed ID: 3523250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of cyclocytidine in reinduction and maintenance therapy of children with acute nonlymphocytic leukemia previously treated with cytosine arabinoside: a report from Children's Cancer Study Group.
    Movassaghi N; Higgins G; Pyesmany A; Baehner R; Chard R; Sather H; Hammond D
    Med Pediatr Oncol; 1984; 12(5):352-6. PubMed ID: 6208468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials of teniposide (VM-26) in childhood acute lymphocytic leukemia.
    Rivera GK; Evans WE
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):51-8. PubMed ID: 1411639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [High-dose cytarabine treatment in acute leukemias and leukemic meningiosis: clinical aspects and pharmacokinetics].
    Nowrousian MR; Seeber S; Miller AA; Anders C; Ohl S; Schmidt CG
    Onkologie; 1985 Feb; 8(1):26-32. PubMed ID: 3885117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity study of cytosine arabinoside and methotrexate in the maintenance therapy of childhood leukemia. A Southwest Oncology Group study.
    Nitschke R; Komp DM; Morgan SK; Starling KA; Vietti TJ
    J Clin Pharmacol; 1978; 18(2-3):131-5. PubMed ID: 272368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential high-dose cytosine arabinoside and asparaginase in refractory acute leukemia.
    Capizzi RL; Cheng YC
    Med Pediatr Oncol; 1982; 10 Suppl 1():221-8. PubMed ID: 6962320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children.
    Belasco JB; Luery N; Scher C
    Cancer; 1990 Dec; 66(12):2492-7. PubMed ID: 2249189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group Study.
    Ryan DH; Kopecky KJ; Head D; Gumbart CN; Grever MR; Karanes C; Weick JK; Coltman CA
    Cancer Treat Rep; 1987; 71(7-8):713-6. PubMed ID: 3475171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose cytosine arabinoside in the management of refractory acute leukaemia.
    Willemze R; Zwaan FE; Colpin G; Keuning JJ
    Scand J Haematol; 1982 Aug; 29(2):141-6. PubMed ID: 6958004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
    Navajas Gutiérrez A; Bezanilla Regato JL; Moya Calderón E; Piñán MA
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():91-3. PubMed ID: 3214046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.